This report concentrates on three main areas. First and foremost, we set the background context for RhD NIPD in prenatal care. While the methodology chapter describes how the literature review was carried out and how additional information was collected, the second chapter provides an overview of the key issues associated with pregnancy of RhD negative women. We present background information based on publications from 1997 to 2006 which describe the genetic condition and its prevalence (RhD negativity) in populations, as well as the frequency of cases of sensitisation and HDN (haemolytic disease of the newborn). We also discuss current service provision for RhD negative women in a number of European countries and look at how the NIPD test...
Objective To determine the accuracy of non-invasive fetal testing for the RHD gene in week 27 of pre...
OBJECTIVE: Evaluate the costs of offering non-invasive prenatal diagnosis (NIPD) for single gene dis...
peer reviewed[en] OBJECTIVES: In some European countries, non-invasive fetal RHD genotyping is the f...
This report concentrates on three main areas. First and foremost, we set the background context for...
Articles reporting the diagnostic accuracy of non-invasive prenatal diagnostic (NIPD) tests for RHD ...
The availability of noninvasive prenatal diagnosis for the fetal RhD status (NIPD RhD) is an obvious...
The availability of noninvasive prenatal diagnosis for the fetal RhD status (NIPD RhD) is an obvious...
BACKGROUND: High-throughput non-invasive prenatal testing (NIPT) for fetal Rhesus D (RhD) status cou...
Background: High-throughput non-invasive prenatal testing (NIPT) for fetal rhesus (D antigen) (RhD) ...
Abstract Background High-throughput non-invasive prenatal testing (NIPT) for fetal Rhesus D (RhD) st...
Background: High-throughput non-invasive prenatal testing (NIPT) for fetal rhesus (D antigen) (RhD) ...
Objective: The goal of this study is to investigate women's preferences and information needs for ro...
OBJECTIVE: Prenatal and postnatal RhD prophylaxis reduces the risk of RhD immunization in pregnancie...
BACKGROUND: Cell-free fetal DNA (cffDNA) is present in the maternal blood from around 4 weeks gestat...
Objective To determine the accuracy of non-invasive fetal testing for the RHD gene in week 27 of pre...
Objective To determine the accuracy of non-invasive fetal testing for the RHD gene in week 27 of pre...
OBJECTIVE: Evaluate the costs of offering non-invasive prenatal diagnosis (NIPD) for single gene dis...
peer reviewed[en] OBJECTIVES: In some European countries, non-invasive fetal RHD genotyping is the f...
This report concentrates on three main areas. First and foremost, we set the background context for...
Articles reporting the diagnostic accuracy of non-invasive prenatal diagnostic (NIPD) tests for RHD ...
The availability of noninvasive prenatal diagnosis for the fetal RhD status (NIPD RhD) is an obvious...
The availability of noninvasive prenatal diagnosis for the fetal RhD status (NIPD RhD) is an obvious...
BACKGROUND: High-throughput non-invasive prenatal testing (NIPT) for fetal Rhesus D (RhD) status cou...
Background: High-throughput non-invasive prenatal testing (NIPT) for fetal rhesus (D antigen) (RhD) ...
Abstract Background High-throughput non-invasive prenatal testing (NIPT) for fetal Rhesus D (RhD) st...
Background: High-throughput non-invasive prenatal testing (NIPT) for fetal rhesus (D antigen) (RhD) ...
Objective: The goal of this study is to investigate women's preferences and information needs for ro...
OBJECTIVE: Prenatal and postnatal RhD prophylaxis reduces the risk of RhD immunization in pregnancie...
BACKGROUND: Cell-free fetal DNA (cffDNA) is present in the maternal blood from around 4 weeks gestat...
Objective To determine the accuracy of non-invasive fetal testing for the RHD gene in week 27 of pre...
Objective To determine the accuracy of non-invasive fetal testing for the RHD gene in week 27 of pre...
OBJECTIVE: Evaluate the costs of offering non-invasive prenatal diagnosis (NIPD) for single gene dis...
peer reviewed[en] OBJECTIVES: In some European countries, non-invasive fetal RHD genotyping is the f...